• IBA (Ion Beam Applications S.A.) announced the sale of IBA Molecular (IBAM) in which IBA had a 40 percent stake, to funds advised by CapVest Partners LP (“CapVest”), has closed successfully.
  • New research shows that innovative scanning-led surveillance can help identify the need for, and guidance of, neck dissection for head and neck cancer patients. This discovery means patients may no longer have to undergo invasive post-treatment surgery to remove remaining cancer cells.
  • Siemens Healthcare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Biograph Horizon positron emission tomography/computed tomography (PET/CT) system, which offers premium performance at a low total cost of ownership.
  • In October, Siemens Healthcare debuted a host of imaging systems that enable RT professionals to go further in the direction of personalized therapy.
  • Siemens’ PETNET Solutions Inc., a wholly owned subsidiary of Siemens Healthcare, will formulate the VPAC1 molecular biomarker 64Cu TP-3805 exclusively for clinical trials for the biopharmaceutical firm NuView Life Sciences Inc., of Park City, Utah.

PET/MR images courtesy of GE Healthcare

Blog | Molecular Imaging | April 27, 2016
In the world of molecular imaging, PET/MR is a wild card. But it’s a wild card that’s ready to be played. Three major...
UltraSPECT, 10th anniversary, WBR technology, Wide Beam Reconstruction, FDA approval, nuclear imaging
News | Nuclear Imaging | April 21, 2016
UltraSPECT Inc. announced the 10th anniversary of the U.S. Food and Drug Administration (FDA) approval of its Wide Beam...
Mirada Medical, The Christie Hospital, England, PET-MRI, radiation therapy
News | Nuclear Imaging | April 20, 2016
Mirada Medical announced a new agreement to work with the clinicians and physicists at The Christie Hospital in...

Photo courtesy of Pixabay

Blog | Molecular Imaging | April 20, 2016
It’s been a long time since radiology focused just on the detection of disease. And it will never see those days again.

Graphic courtesy Pixabay

Blog | Molecular Imaging | April 13, 2016
The intersection between PET/CT and radiation therapy is widening. And it is doing so in unanticipated ways.
PET, Hodgkin lymphoma, chemotherapy, remission, U.S. trial
News | PET Imaging | April 13, 2016
Using positron emission tomography (PET) to guide chemotherapy treatment significantly increases the number of people...

Image courtesy Siemens Healthcare

Blog | PET-CT | April 06, 2016
The good news for molecular imaging is that the latest generation of PET/CT can visualize more and subtler signs of...
PET/CT scan, brain stress center, heart disease predictor, ACC.16
News | PET-CT | April 05, 2016
New research shows individuals with a greater degree of activity in the stress center of the brain also have more...
PET imaging, cancer treatment, UCLA study, Caius Radu, dCK
News | PET Imaging | March 29, 2016
A promising new discovery by University of California Los Angeles (UCLA) scientists could lead to a new method of...
IBA, sale, IBA Molecular, proton therapy, radiopharmaceuticals
News | Radiopharmaceuticals and Tracers | March 29, 2016
IBA (Ion Beam Applications S.A.) announced the sale of IBA Molecular (IBAM) in which IBA had a 40 percent stake, to...
PET-CT, head and neck cancer, U.K. study, persistent cells

Scans showing the remaining surviving cancer cells after treatment. Image courtesy of University of Birmingham

News | PET-CT | March 23, 2016
New research shows that innovative scanning-led surveillance can help identify the need for, and guidance of, neck...
PET/CT, oropharyngeal cancer, recurrence, study, Multidisciplinary Head and Neck Cancer Symposium
News | PET-CT | March 16, 2016
For patients treated with definitive radiation therapy (RT) for oropharyngeal cancer caused by human papillomavirus (...
MRI, fluorine tracer agent, UC San Diego, Eric Aherns
News | Magnetic Resonance Imaging (MRI) | March 14, 2016
March 14, 2016 — Writing in the March 14 online issue of Nature Materials, researchers at University of Cali
Alzheimer's disease, IDEAS study, patient enrollment open, amyloid PET scan
News | PET Imaging | March 03, 2016
Participating dementia specialists may now enroll patients in the Imaging Dementia—Evidence for Amyloid Scanning (IDEAS...
News | Radiopharmaceuticals and Tracers | March 01, 2016
March 1, 2016 — Wisconsin-based Shine Medical Technologies Inc., producer of medical tracers and cancer treatment ele
Alzheimer's disease, oligomers, amyloid plaque, bifunctional chemical agents, Washington University in St. Louis
News | PET Imaging | February 23, 2016
February 23, 2016 — The National Institutes of Health recently bestowed a $1.5 million grant on a Washington Universi
PET scans, lung cancer survivors, overuse, national study
News | PET Imaging | February 22, 2016
A new study suggests that one approach to watching for lung cancer’s return is being inappropriately used at many...
Lymphoseek, cervical cancer study, MD Anderson, sentinel lymph node biopsy, SLNB
News | Radiopharmaceuticals and Tracers | February 18, 2016
Navidea Biopharmaceuticals Inc. last week announced that the first patient has been enrolled in a clinical study...
Weill Cornell Medicine, Senior Scientific, magnetix relaxometry, MRX technology, prostate cancer detection
News | Prostate Cancer | February 18, 2016
Manhattan Scientifics Inc. announced its wholly-owned subsidiary Senior Scientific LLC, which is developing a platform...
Toshiba Celesteion PET/CT, Fox Valley Hematology & Oncology
News | PET-CT | February 10, 2016
Patients at Fox Valley Hematology & Oncology’s (FVHO) new cancer care center are receiving a better imaging...
Overlay Init